Chemoenzymatic synthesis of enantiopure 1,4-dihydropyridine derivatives

References

• Aboul-Enein, H.Y. and Wainer, I.W. (1997) The impact of stereo chemistry on drug development and use (John Wiley & Sons).
   Google Scholar
• Achiwa, K. and Kato, T. (1999) Asymmetric synthesis of optically active-dihydropyridines as calcium antagonists, Curr. Org. Chem. 3, 77- 106.
   Google Scholar
• Adachi, T., Ishii, M., Ohta, Y., Ota, T., Ogawa, T. and Hanada, K. (1993) Chemoenzymatic synthesis of optically active 1,4–1,4 dihydropyridine derivatives via enantioselective hydrolysis and transesterification, Tetrahedron: Asymmetry 4, 2061–2068.
   Google Scholar
• Alajarin, R., Vaquero, J.J., Alvarez-Builla, J., Pastor, M., Sunkel, C, Fau de Casa-Juana, M., Priego, J., Statkow, PR., Sanz-Aparicio, J. and Fonseca, I. (1995) Synthesis, structure, and pharmaceutical evaluation of stereomers of furnidipine, J. Med. Chem. 38, 2830–2841.
   Google Scholar
• Ashimori, A., Uchida, T., Ohtaki, Y, Tanaka, M., Ohe, K., Fukaya, C, Watanabe, M., Kagitani, M. and Yokoyama, K. (1991) Synthesis and pharmacological effects of optically active 2-(4-(4-benzhydryl-1-piperazinyl)phenyl)ethyl methyl 1,4-dihy-dro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride, Chem. Pharm. Bull. 39, 108–111.
   Google Scholar
• Beudeker, H.J., van der Velden, J.W. and van der Aar, E.M. (2000) Interaction profile and tolerability of barnidipine, Int. J. Clin. Pract. Suppl. 114, 36–40.
   Google Scholar
• Bird, G.L., Prach, A.T., McMahon, A.D., Forrest, J.A., Mills, PR. and Danesh, B.J. (1998) Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis, J. Hepatol. 28,194- 198.
   Google Scholar
• Bisenieks, E.A., Uldrikis, J.R., Kirule, I.E., Tirzit, G.D. and Dubur, G.J. (1982) Synthesis and antioxidant activities of 2-methyl-5-oxo-1,4-dihydroindeno(1,2-b)pyridines. Khim. Geterotsikl. Soed. 1528–1531.
   Google Scholar
• Bossert, F and Vater, W. (1971) Dihydropyridines, a new group of strongly effective coronary therapeutic agents, Naturwis-senschaften 58, 578.
   Google Scholar
• Briede, J., Daija, D., Stivrina, M. and Duburs, G. (1999) Effect of cerebrocrast on lymphocyte blast transformation activity in normal and streptozotocin induced diabetic rats, Cell. Bio-chem. Func. 17, 89–96.
   PubMed Web of Science ®Google Scholar
• Caballero, E., Puebla, P., Sanchez, M., Medarde, M., del Prado, L.M. and Feliciano, A.S. (1996a) Enantiospecific synthesis of dihydropyridines from chiral enamines, Tetrahedron: Asymmetry 7, 1985–1994.
   Google Scholar
• Caballero, M., Puebla, P., Medarde, M., Sanchez, M., Salvado, M.A., Garcia-Granda, S. and San Feliciano, A. (1996b) Synthesis of enantiopure 2,3,8,8a-tetrahydro-7h-oxazolo(3,2-a)pyridine derivatives, J. Org. Chem. 61, 1890–1893.
   Google Scholar
• Caccamese, S., Chillemi, R. and Principato, G. (1996) Fluorenone 1,4-dihydropyridine derivatives with cardiodepressant activity: enantiomeric separation by chiral HPLC and conformational aspects, Chirality 8, 281–290.
   Google Scholar
• Chekavichus, B.S., Sausins, A.E. and Dubur, G.J. (1982) Effect of substituents in the dihydropyridine ring on the reactivity of the ester group of 3,5-dialkoxycarbonyl-1,4-dihydropyri-dines. Khim. Geterotsikl. Soed. 1072-1077.
   Google Scholar
• Chekavichus, B.S., Sausins, A.E., Zolotoyabko, R.M. and Dubur, G.J. (1985) 2,6-Di(aryl)-3,5-dialkoxycarbonyl-1,4-dihydropyr-idines. Latvijas PSR ZA vestis, Chem. ser. 77-85.
   Google Scholar
• Chen, C.S., Fujimoto, Y, Girdaukas, G. and Sih, C.J. (1982) Quantitative analyses of biochemical kinetic resolution of enantiomers, J. Am. Chem. Soc. 104, 7294–7299.
   Web of Science ®Google Scholar
• Cheng, C.Y., Chen, J.Y. and Lee, M.J. (1996) An asymmetric synthesis of 4-aryl-1,4-dihydropyridines, Heterocycles 43, 2425–2434.
   Google Scholar
• Daniels, J.M.D., Nestmann, E.R. and Kerr, A. (1997) Development of stereoisomeric (chiral) drugs: a brief review of scientific and regulatory considerations, Drug Inf. J. 31, 639–646.
   Google Scholar
• de Castro, M.S., Salazar, L. and Sinisterra, J.V. (1997) Influence of the N-MOM group in the enantioselective lipase catalyzed methanolysis of racemic 1,4-dihydropyridine dicarboxylates, Tetrahedron: Asymmetry 8, 857–858.
   Google Scholar
• Ebiike, H., Maruyama, K. and Achiwa, K. (1992a) Enzymatic synthesis of optically active 2-carbamoyloxymethyl-1,4-dihy-dropyridines, (R)-(+)-and (S)-(—)-NB 818, Tetrahedron Lett. 3, 1153–1156.
   Google Scholar
• Ebiike, H., Maruyama, K. and Achiwa, K. (1992b) Lipase-catalyzed enantioselective hydrolysis of 4-alkyl-1,4-dihydro-pyridine derivatives: synthesis of (+)-and (—)-methyl 2-(phenylthio)ethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridine-dicarboxylate (PCA 4248), Chem. Pharm. Bull. 40, 1083–1085.
   Google Scholar
• Ebiike, H., Maruyama, K., Ozawa, Y., Yamazaki, Y and Achiwa, K. (1997a) Asymmetric synthesis of (R)-nilvadipine and (S)-NB 818 via regioselective bromination of chiral 1,4-dihydropyr-idines as a key step and enzymatic resolution of racemic 2-hydroxymethyl-1,4-dihydropyridine derivatives, Chem. Pharm. Bull. 45, 869–876.
   Google Scholar
• Ebiike, H., Maruyama, K., Yamazaki, Y, Hirose, Y, Kariya, K., Sasaki, I., Kurono, Y, Terao, Y and Achiwa, K. (1997b) Lipase-catalyzed enantioselective hydrolysis of bis(acyloxy-methyl) 1,4-dihydro-3,5-pyridinedicarboxylates leading to optically active medicines, Chem. Pharm. Bull. 45, 863–868.
   Google Scholar
• Ebiike, H., Ozawa, Y, Achiwa, K., Hirose, Y, Kariya, K., Sasaki, I. and Kurono, Y (1993) Enzyme-catalyzed synthesis of biologically active (S)-nilvadipine, Heterocycles 35, 603–606.
   Google Scholar
• Ebiike, H., Terao, Y and Achiwa, K. (1991) Acyloxymethyl as activating group in lipase-catalyzed enantioselective hydrolysis. A versatile approach to chiral 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates, Tetrahedron Lett. 32, 5805–5808.
   Google Scholar
• Ebiike, H., Yamazaki, Y and Achiwa, K. (1995) Lipase-catalyzed enantiosynthesis of (R)-and (S)-2-(benzyl(phenyl)ami-no)ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridine-carboxylate (NZ 105), Chem. Pharm. Bull. 43, 1251–1253.
   Google Scholar
• Eisner, U. and Kuthan, J. (1972) Chemistry of dihydropyridines, Chem. Rev. 72, 1–42.
   Web of Science ®Google Scholar
• Emanuel’, N.M., Obukhova, L.K., Dubur, G.J., Tirzit, G.D. and Uldrikis, J.R. (1985) Geroprotective activity of 2,6-dimethyl-3,5-diethoxycarbonyl-l,4-dihydropyridine, Dokl. Akad. Nauk SSSR 284, 1271-1274.
   Google Scholar
• Enders, D., Muller, S. and Demir, A.S. (1988) Enantioselective Hantzsch dihydropyridine synthesis via metalated chiral alkyl acetoacetate hydrazones, Tetrahedron Lett. 29, 6437–6440.
   Web of Science ®Google Scholar
• Faber, K. (1997) Biotransformations in organic chemistry (Springer-Verlag, Berlin, Heidelberg).
   Google Scholar
• Franckowiak, J., Boshagen, H., Bossert, F., Goldmann, S., Meyer, H., Wehinger, E., Stoltefuss, J., Schramm, M., Thomas, J. and Towart, R. (1983) Dihydropyridines having positively inotropic action, novel compounds, their use in medicaments and processes for their preparation. DE 3206671; Chem. Abstr. 98, 198038 (1983).
   Google Scholar
• Genain, G. (1988) Resolution of 1,4-dihydropyridine derivatives. EP 0273349; esp@cenet database:http://www.espacenet.com
   Google Scholar
• Germane, S., Misane, I. and Klusa, V. (1995) Alcohol-induced accelerated aging in mice: A convenient model for testing the normalizing influence of cerebrocrast on the altered CNS functioning, Laboratornye Zhyvotnye 5, 73–81.
   Google Scholar
• Goldmann, S. and Stoltefuss, J. (1991) 1,4-Dihydropyridines: Effects of chirality and conformation on the calcium antagonist and calcium agonist activities, Angew. Chem., Int. Ed. Engl. 30, 1559-1578.
   Web of Science ®Google Scholar
• Goldmann, S., Stoltefuss, J. and Born, L. (1992) Determination of the absolute configuration of the active amlodipine enantio-mer as (—)-S: A correction, J. Med. Chem. 35, 3341-3344.
   Google Scholar
• Gorlitzer, K., Kramer, C. and Boyle, C. (2000) Synthesis and transformations of ethyl 1,4-dihydro-4-oxo(1)benzofuro (3,2-b)pyridine-3-carboxylic acid esters: new antibacterial agents, Pharmazie 55, 651–658.
   Google Scholar
• Hantzsch, A. (1881) Condensationsprodukte aus Aldehydammo-niak und ketonartigen Verbindungen, Ber. 14, 1637–1638.
   Google Scholar
• Hantzsch, A. (1882) Uber die Synthese pyridinartige Verbindungen aus Acetessigather und Aldehydammoniak, Justus Lie-bigs Ann. Chem. 215, 1–82.
   Google Scholar
• Hillier, M.C. and Reider, P.J. (2002) Stereoselective synthesis from a process research perspective, Drug Discov. Today 7, 303–314.
   Google Scholar
• Hirose, Y, Kariya, K., Sasaki, I., Kurono, Y and Achiwa, K. (1993a) Carbamoylmethyl group as an activated group in protease-and base-catalyzed transesterification of 1,4-dihydropyri-dines: a novel asymmetric synthesis of valnidipine, Tetrahedron Lett. 34, 5915–5918.
   Google Scholar
• Hirose, Y, Kariya, K., Sasaki, I., Kurono, Y and Achiwa, K. (1993b) Protease-catalyzed enantioselective synthesis of optically active 1,4-dihydropyridines, Tetrahedron Lett. 34, 3441–3444.
   Google Scholar
• Hirose, Y, Kariya, K., Sasaki, I., Kurono, Y, Ebiike, H. and Achiwa, K. (1992) Drastic solvent effect on lipase-catalyzed enantioselective hydrolysis of prochiral 1,4-dihydropyridines, Tetrahedron Lett. 33, 7157–5918.
   Web of Science ®Google Scholar
• Holdgrun, X.K. and Sih, C.J. (1991) A chemoenzymatic synthesis of optically-active dihydropyridines, Tetrahedron Lett. 32, 3465–3468.
   Web of Science ®Google Scholar
• Hyvonen, Z., Plotniece, A., Reine, I., Chekavichus, B., Duburs, G. and Urtti, A. (2000) Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery, Biochim. Biophys. Acta 1509, 451–466.
   PubMed Web of Science ®Google Scholar
• Hyvonen, Z., Ruponen, M., Ronkko, S., Suhonen, P. and Urtti, A. (2002) Extracellular and intracellular factors influencing gene transfection mediated by 1,4-dihydropyridine amphiphiles, Eur. J. Pharm. Sci. 15, 449–460.
   PubMed Web of Science ®Google Scholar
• Inotsume, N. and Nakano, M. (2002) Stereoselective determination and pharmacokinetics of dihydropyridines: an updated review, J. Biochem. Biophys. Methods 54, 255–274.
   Google Scholar
• Inouye, M., Mio, T. and Sumino, K. (2000) Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis, Eur. J. Clin. Pharmacol. 56, 35–41.
   Google Scholar
• Iqbal, N., Vo, D., McEwen, C.A., Wolowyk, M.W. and Knaus, E.E. (1994) Enantioselective syntheses and calcium channel modulating effects of (+)-and (—)-3-isopropyl 5-(4-methyl-phenethyl) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyri-dinedicarboxylates, Chirality 6, 515–520.
   Google Scholar
• Ivanov, E.V., Ponomarjeva, TV., Merkusev, G.N., Dubur, G.J., Bisenieks, E.A., Dauvarte, A.Z. and Pilscik, E.M. (1990) A new skin radioprotective agent Diethon (experimental study), Radiobiol. Radiother. 31, 69–78.
   Google Scholar
• Klegeris, A., Liutkevicius, E., Mikalauskiene, G., Duburs, G., McGeer, PL. and Klusa, V (2002) Anti-inflammatory effects of cerebrocrast in a model of rat raw edema and mononuclear THP-1 cells, Eur. J. Pharmacol. 441, 203–208.
   PubMed Web of Science ®Google Scholar
• Klusa, V (1995) Cerebrocrast: Neuroprotectant, cognition enhancer, Drugs of the Future 20, 135–138.
   Google Scholar
• Klusa, V and Duburs, G. (1996) Cognition enhancers (Nootropic drugs), Acta Medica Baltica 3, 104–114.
   Google Scholar
• Klusa, V and Germane, S. (1996) Alcoholized maternal rat offspring: a model for testing the physical and psychoemo-tional neurodeficit, Scand. J. Lab. Anim. Sci. 23, 403–409.
   Google Scholar
• Kobayashi, T, Inoue, T, Nishino, S., Fujihara, Y, Oizumi, K. and Kimura, T (1995) Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3-and/or 5-position, Chem. Pharm. Bull. 43, 797–817.
   Google Scholar
• Kongsamut, S., Kamp, T.J., Miller, R.J. and Sanguinetti, M.C. (1985) Calcium channel agonist and antagonist effects of the stereomers of the dihydropyridine 202–791, Biochem. Biophys. Res. Commun. 130, 141–148.
   Google Scholar
• Kozlov, E.I., Ivanova, R.A., Dubur, G.J. and Uldrikis, J.R. (1978) Dihydropyridine derivatives-new effective stabilizers of vitamin A oil solutions, Khim.-Farm. Zh. 12, 101–105.
   Google Scholar
• Kumsar, K.K., Velena, A.H., Dubur, G.J., Uldrikis, J.P and Zidermane, A.A. (1971) Effect of 1,4-dihydropyridine and 1,6-dihydropyrimidine derivatives on energy metabolism of normal and tumor cells, Biokhimiia 36, 1204–1208.
   Google Scholar
• Kuthan, J. and Kurfurst, A. (1982) Development in dihydropyr-idine chemistry, Ind. Eng. Chem. Prod. Res. Dev. 21, 191–261.
   Google Scholar
• Kuzhir, T.D., Dalivelia, O.V. and Savina, N.V. (1999) Modification of the repair processes in chemical mutagenesis in Droso-phila melanogaster, Genetika 35, 919–924.
   Google Scholar
• Lamm, B., Simonsson, R. and Sundell, S. (1989) Synthesis of enantiomers of fellodipine and determination of their abso-lute configuration, Tetrahedron Lett. 30, 6423–6426.
   Web of Science ®Google Scholar
• Loev, B. and Goodman, M.M. (1975) “Hantzsch-type” dihydro-pyridines. IV(1). Carboxylic acids, J. Heterocycl. Chem. 12, 363–365.
   Google Scholar
• Mantle, D., Patel, V.B., Why, H.J., Ahmed, S., Rahman, I., MacNee, W., Wassif, W.S., Richardson, P.J. and Preedy, V.R. (2000) Effects of lisinopril and amlodipine on antioxidant status in experimental hypertension, Clin. Chim. Acta 299, 1–10.
   PubMed Web of Science ®Google Scholar
• Marchalin, S., Chudik, M., Mastihuba, V. and Decroix, B. (1998) Use of enzymes in preparation of enantiopure 1,4-dihydro-pyridines, Heterocycles 48, 1943–1957.
   Google Scholar
• Martin-Caraballo, M., Triggle, C.R. and Bieger, D. (1995) Photo-sensitization of oesophageal smooth muscle by 3-NO2-1, 4-dihydropyridines: evidence for two cyclic GMP-dependent effector pathways, Br. J. Pharmacol. 116, 3293–3301.
   Google Scholar
• Misane, I., Klusa, V., Dambrova, M., Germane, S., Duburs, G., Bisenieks, E., Rimondini, R. and Ogren, S.O. (1998) ”Atypical” neuromodulatory profile of glutapyrone, a representative of a novel ‘class’ of amino acid containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: In vitro and in vivo studies, Eur. Neuropsychopharmacol. 8, 329–347.
   PubMedGoogle Scholar
• Miyashita, K., Nishimoto, M., Ishino, T., Obika, S. and Imanishi, T. (1995) Novel and chiral Hantzsch-type 1,4-dihydropyridines having a tolylsulfinyl group. Synthesis and biological activities as calcium channel antagonists, Chem. Pharm. Bull. 43, 711–713.
   Google Scholar
• Morgan, B., Zaks, A., Dodds, D.R., Liu, J., Jain, R., Megati, S., Njoroge, F.G. and Girijavallabhan, V.M. (2000) Enzymatic kinetic resolution of piperidine atropisomers: Synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336, J. Org. Chem. 65, 5452–5459.
   Google Scholar
• Natale, N.R. (2000) Learning from the Hantzsch synthesis, Chemical Innovation 30, 22–28.
   Google Scholar
• Ogawa, T., Hatayama, K., Maeda, H. and Kita, Y. (1994) Mild and facile cleavage of 2-cyanoethyl ester using sodium sulfide or tetrabutylammonium fluoride. Syntheis of 1,4-dihydropyridine monocarboxylic acids and unsymmetrical 1,4-dihydropyridine dicarboxylates, Chem. Pharm. Bull. 42, 1579–1589.
   Google Scholar
• Ogawa, T., Matsumoto, K., Yokoo, C., Hatayama, K. and Kita-mura, K. (1993) Synthesis and configurational assignment of methyl 3-nitrooxypropyl-1,4-dihydro-2,6-dimethyl-4-(3-ni-trophenyl)pyridine-3,5-carboxylate. J. Chem. Soc. Perkin Trans. 1 525–528.
   Google Scholar
• Reeve, C.D., Crout, D.H.G., Cooper, K. and Fray, M.J. (1992) An optically pure 1,4-dihydropyridine from a resolution catalysed rabbit liver esterase, Tetrahedron: Asymmetry 3, 785–794.
   Google Scholar
• Robertson, R.M. and Robertson, D. (1996) Drugs used for the treatment of myocardial ischemia, In: Hardman, J.G., Lim-bird, L.E., Molinoff, P.B., Ruddon, R.W. and Goodman Gilman, A., eds, Goodman and Gilman’s: The pharmacological basis of therapeutics (McGraw-Hill Companies, Inc), pp. 759–779.
   Google Scholar
• Rubene, D.J., Tirzit, G.D. and Dubur, G.J. (1982) Interaction of some derivatives of 1,4-dihydropyridine with Fenton’s reagent. Latvijas PSR ZA vestis, Chem. ser. 212–215.
   Google Scholar
• Salazar, L. and Sih, C.J. (1995) Optically-active dihydropyridines via lipase-catalyzed enantioselective hydrolysis, Tetrahedron: Asymmetry 6, 2917–2920.
   Google Scholar
• Sausins, A. and Duburs, G. (1988) Synthesis of 1,4-dihydropyridines by cyclocondensation reactions, Heterocycles 27, 269–289.
   Web of Science ®Google Scholar
• Sausins, A. and Duburs, G. (1992) Synthesis of 1,4-dihydropyridines in cyclocondensation reactions. Khim. Geterotsikl. Soed. 435–467.
   Google Scholar
• Sausins, A. and Duburs, G. (1993) Reactions of 1,4-dihydropyridines. Khim. Geterotsikl. Soed. 579–612.
   Google Scholar
• Shah, A., Gaveriya, H., Motohashi, N., Kawase, M., Saito, S., Sakagami, H., Satoh, K., Tada, Y, Solymosi, A., Walfard, K. and Molnar, J. (2000) 3,5-Diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells, Anticancer Res. 20, 373-377.
   Google Scholar
• Shan, R., Howlett, S.E. and Knaus, E.E. (2002) Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl) pyridine-5-carboxylate enantiomers, J. Med. Chem. 45, 955–961.
   Google Scholar
• Shibanuma, T., Iwanani, M., Okuda, K., Takenaka, T. and Murakami, M. (1980) Synthesis of optically active 2-(N-benzyl-N-methylamino)ethyl methyl-2,6-dimethyl-4-(m-ni-trophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (Nicardipine), Chem. Pharm. Bull. 28, 2809–2812.
   Google Scholar
• Sih, C.J., Gu, S.Q., Holdgrun, X. and Harris, K. (1992) Optically-active compounds via biocatalytic methods, Chirality 4, 91–97.
   Google Scholar
• Sobolev, A., Franssen, M.C.R., Makarova, N., Duburs, G. and de Groot, A. (2000) C. antarctica lipase catalyzed hydrolysis of 4-substituted bis (ethoxycarbonylmethyl) 1,4-dihydropyridine-3,5-dicarboxylates as the key step in the synthesis of optically active dihydropyridines, Tetrahedron: Asymmetry 11, 4559–4569.
   Web of Science ®Google Scholar
• Sobolev, A., Franssen, M.C.R., Poikans, J., Duburs, G. and de Groot, A. (2002a) Enantioselective lipase-catalysed kinetic resolution of acyloxymethyl and ethoxycarbonylmethyl esters of 1,4-dihydroisonicotinic acid derivatives, Tetrahedron: Asymmetry 13, 2389-2397.
   Google Scholar
• Sobolev, A., Franssen, M.C.R., Vigante, B., Cekavicus, B., Makarova, N., Duburs, G. and de Groot, A. (2001) An efficient chemoenzymatic approach to enantiomerically pure 4-[2-(difluoromethoxy)phenyl] substituted 1,4-dihydropyridine-3,5-dicarboxylates, Tetrahedron: Asymmetry 12, 3251-3256.
   Google Scholar
• Sobolev, A., Franssen, M.C.R., Vigante, B., Cekavicus, B., Zhalu-bovskis, R., Kooijman, H., Spek, A.L., Duburs, G. and de Groot, A. (2002b) The effect of acyl chain length and branching on the enantioselectivity of C. rugosa lipase in the kinetic resolution of 4-(2-difluoromethoxyphenyl) substituted 1,4-dihydropyridine 3,5-diesters, J. Org. Chem. 67, 401–410.
   Google Scholar
• Soons, PA., Roosemalen, M.C.M. and Breimer, D.D. (1990) Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma, J. Chromatogr. 528,343–356.
   Google Scholar
• Stout, D.M. and Meyers, A.I. (1982) Recent advances in the chemistry of dihydropyridines, Chem. Rev. 82, 223–243.
   Web of Science ®Google Scholar
• Strong, M. (1999) FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs, Food Drug Law J. 54, 463–487.
   PubMed Web of Science ®Google Scholar
• Suh, J.J. and Hong, YH. (1989a) Synthesis of 1,4-dihydropyridine carboxylic acids, Yakhak Hoechi 33, 80–86.
   Google Scholar
• Suh, J.J. and Hong, YH. (1989b) Synthesis of 1,4-dihydropyridine carboxylic acids (II), Yakhak Hoechi 33, 219–225.
   Google Scholar
• Tarasenko, L.M., Neporada, K.S. and Klusha, V. (2002) Stress-protective effect of glutapyrone belonging to a new type of amino acid-containing 1,4-DHPs on peridontal tissues and stomach in rats with different resistance to stress, Bull. Exp. Biol. Med. 133,369–371.
   PubMedGoogle Scholar
• Tirzitis, G., Kirule, I. and Duburs, G. (1988) Antioxidationsaktivi-taet der 3,5-Dicarbonylderivate des 2,6-Dimethyl-1,4-Dihy-dropyridins, Fat. Sci. Technol. 90, 411–413.
   Google Scholar
• Tokuma, Y and Noguchi, H. (1995) Stereoselective pharmacokinetics of dihydropyridine calcium antagonists, J. Chromatogr. A. 694, 181–193.
   PubMed Web of Science ®Google Scholar
• Triggle, D.J. (2003) 1,4-Dihydropyridines as calcium channel ligands and privileged structures, Cell. Mol. Neurobiol. 23, 293–303.
   PubMed Web of Science ®Google Scholar
• Uldrikis, Y.R., Preisa, I.E., Dubur, G.Y, Zidermane, A.A., Biseniex, E.A. and Tirzit, G.D. (1980) 2,6-Dimethyl-1,4-dihydropyri-dine-3,5-dicarboxylic acid esters and method for preparing same. US 4293700; Chem. Abstr. 93, 168135 (1980).
   Google Scholar
• Uno, T, Ohkubo, T and Sugawara, K. (1997) Enantioselective high-performance liquid chromatographic determination of nicardipine in human plasma, J. Chromatogr. B 698, 181–186.
   PubMed Web of Science ®Google Scholar
• van Zwieten, PA. (1998) Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist, Blood Press. Suppl. 1, 5–8.
   PubMedGoogle Scholar
• Velena, A., Zilbers, J. and Duburs, G. (1999) Derivatives of 1,4-dihydropyridines as modulators of ascorbate-induced lipid peroxidation and high-amplitude swelling of mitochondria, caused by ascorbate, sodium linoleate and sodium pyrophosphate, Cell Biochem. Funct. 17, 237–252.
   Google Scholar
• Vo, D., Matowe, W.C., Ramesh, M., Iqbal, N., Wolowyk, M.W., Howlett, S.E. and Knaus, E.E. (1995) Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enan-tiomers, J. Med. Chem. 38, 2851–2859.
   PubMed Web of Science ®Google Scholar
• Vogel, A. (1983) 1,4-Dihydropyridine derivatives, preparation thereof and pharmaceutical compositions containing them. DE 3320616; Chem. Abstr. 101, 7162s (1984).
   Google Scholar
• Watson, W.P. and Little, H.J. (1999) Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice, Alcohol Alcohol. 34, 35–42.
   Google Scholar
• Yamazaki, Y. and Achiwa, K. (1996) Lipase AH-catalyzed asymmetric synthesis of (S)-(—)-NB 818, Heterocycles 42, 169–171.
   Google Scholar
• Yamazaki, Y, Ebiike, H. and Achiwa, K. (1994) Determination of the absolute configuration of biologic105ally active (S)-(—)-NB 818 and its structural correlation with the stereoselectivity of the channel blocking action, Chem. Pharm. Bull. 42, 1968–1970.
   Google Scholar
• Yao, K., Ina, Y, Nagashima, K., Ohmori, K. and Ohno106, T. (0522000) Antioxidant effects of calcium a237ntagonists in rat brain homogenates, Biol. Pharm. Bull. 23, 766–769.
   PubMed Web of Science ®Google Scholar